Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Pereira 2009 Biochem J"

From Bioblast
Line 15: Line 15:
}}
}}
{{Labeling
{{Labeling
|area=Respiration
|diseases=Cancer
|organism=Human
|organism=Human
|tissues=Liver
|tissues=Liver
|preparations=Intact cells
|preparations=Intact cells, Permeabilized cells
|diseases=Cancer
|couplingstates=LEAK, ROUTINE, OXPHOS, ETS
|pathways=S, ROX
|instruments=Oxygraph-2k
|instruments=Oxygraph-2k
}}
}}

Revision as of 10:03, 8 November 2017

Publications in the MiPMap
Pereira da Silva AP, El-Bacha T, Kyaw N, dos Santos RS, Da Silva WS, Almeida FC, Da Poian AT, Galina A (2009) Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate. Biochem J 417:717-26.

ยป PMID: 18945211 Open Access

Pereira da Silva AP, El-Bacha T, Kyaw N, dos Santos RS, Da Silva WS, Almeida FC, Da Poian AT, Galina A (2009) Biochem J

Abstract: 3-BrPA (3-bromopyruvate) is an alkylating agent with antitumoral activity on hepatocellular carcinoma. This compound inhibits cellular ATP production owing to its action on glycolysis and oxidative phosphorylation; however, the specific metabolic steps and mechanisms of 3-BrPA action in human hepatocellular carcinomas, particularly its effects on mitochondrial energetics, are poorly understood. In the present study it was found that incubation of HepG2 cells with a low concentration of 3-BrPA for a short period (150 ฮผMfor 30 min) significantly affected both glycolysis and mitochondrial respiratory functions. The activity of mitochondrial hexokinase was not inhibited by 150 ฮผM 3-BrPA, but this concentration caused more than 70% inhibition of GAPDH (glyceraldehyde-3-phosphate dehydrogenase) and 3-phosphoglycerate kinase activities. Additionally, 3-BrPA treatment significantly impaired lactate production by HepG2 cells, even when glucose was withdrawn from the incubation medium. Oxygen consumption of HepG2 cells supported by either pyruvate/malate or succinate was inhibited when cells were preincubated with 3-BrPA in glucose-free medium. On the other hand, when cells were pre-incubated in glucose-supplemented medium, oxygen consumption was affected only when succinate was used as the oxidizable substrate. An increase in oligomycinindependent respiration was observed in HepG2 cells treated with 3-BrPA only when incubated in glucose-supplemented medium, indicating that 3-BrPA induces mitochondrial proton leakage as well as blocking the electron transport system. The activity of succinate dehydrogenase was inhibited by 70% by 3-BrPA treatment. These results suggest that the combined action of 3- BrPA on succinate dehydrogenase and on glycolysis, inhibiting steps downstream of the phosphorylation of glucose, play an important role in HepG2 cell death. โ€ข Keywords: 3-bromopyruvate, Glycolysis, Hepatocellular carcinoma, HepG2 cell, Mitochondrion, Oxygen consumption, Tumour cell.

โ€ข O2k-Network Lab: BR Rio de Janeiro Galina A, BR Rio de Janeiro Da Poian AT


Labels: MiParea: Respiration  Pathology: Cancer 

Organism: Human  Tissue;cell: Liver  Preparation: Intact cells, Permeabilized cells 


Coupling state: LEAK, ROUTINE, OXPHOS, ETS"ETS" is not in the list (LEAK, ROUTINE, OXPHOS, ET) of allowed values for the "Coupling states" property.  Pathway: S, ROX  HRR: Oxygraph-2k